WallStSmart

Phreesia Inc (PHR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Phreesia Inc stock (PHR) is currently trading at $11.28. Phreesia Inc PS ratio (Price-to-Sales) is 1.54. Analyst consensus price target for PHR is $28.05. WallStSmart rates PHR as Sell.

  • PHR PE ratio analysis and historical PE chart
  • PHR PS ratio (Price-to-Sales) history and trend
  • PHR intrinsic value — DCF, Graham Number, EPV models
  • PHR stock price prediction 2025 2026 2027 2028 2029 2030
  • PHR fair value vs current price
  • PHR insider transactions and insider buying
  • Is PHR undervalued or overvalued?
  • Phreesia Inc financial analysis — revenue, earnings, cash flow
  • PHR Piotroski F-Score and Altman Z-Score
  • PHR analyst price target and Smart Rating
PHR

Phreesia Inc

NYSEHEALTHCARE
$11.28
$0.00 (0.00%)
52W$10.75
$32.76
Target$28.05+148.7%

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

Phreesia Inc (PHR) · 8 metrics scored

Smart Score

39
out of 100
Grade: F
Hold
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, revenue growth, institutional own.. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.

Phreesia Inc (PHR) Key Strengths (3)

Avg Score: 9.3/10
Revenue GrowthGrowth
45.70%10/10

Revenue surging 45.70% year-over-year

Institutional Own.Quality
113.17%10/10

113.17% of shares held by major funds and institutions

Price/SalesValuation
1.548/10

Paying $1.54 for every $1 of annual revenue

Supporting Valuation Data

Forward P/E
13.33
Attractive
Price/Sales (TTM)
1.544
Undervalued
EV/Revenue
1.337
Undervalued
PHR Target Price
$28.05
112% Upside

Phreesia Inc (PHR) Areas to Watch (5)

Avg Score: 2.2/10
Return on EquityProfitability
-1.87%0/10

Company is destroying shareholder value

Operating MarginProfitability
-46.70%0/10

Losing money on operations

Profit MarginProfitability
-1.16%0/10

Company is losing money with a negative profit margin

Market CapQuality
$715M5/10

Small-cap company with higher risk but more growth potential

Price/BookValuation
2.236/10

Fairly priced relative to book value

Phreesia Inc (PHR) Detailed Analysis Report

Overall Assessment

This company scores 39/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 3 register as strengths (avg 9.3/10) while 5 fall into concern territory (avg 2.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Revenue Growth, Institutional Own., Price/Sales. Valuation metrics including Price/Sales (1.54) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 45.70%.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including Price/Book (2.23) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -1.87%, Operating Margin at -46.70%, Profit Margin at -1.16%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -1.87% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 45.70% strong but requiring continuation.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

PHR Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

PHR's Price-to-Sales ratio of 1.54x trades at a deep discount to its historical average of 9.84x (2th percentile). The current valuation is 95% below its historical high of 31.54x set in Jan 2021, and 8% above its historical low of 1.43x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~3.7x as trailing revenue scaled faster than the stock price.

Compare PHR with Competitors

Top HEALTH INFORMATION SERVICES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Phreesia Inc (PHR) · HEALTHCAREHEALTH INFORMATION SERVICES

The Big Picture

Phreesia Inc is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 463M with 46% growth year-over-year. The company is currently unprofitable, posting a -1.2% profit margin.

Key Findings

Strong Revenue Growth

Revenue growing at 46% YoY, reaching 463M. This pace significantly outperforms most HEALTH INFORMATION SERVICES peers.

Cash Flow Positive

Generating 12M in free cash flow and 15M in operating cash flow. Earnings are translating into actual cash generation.

Operating at a Loss

The company is unprofitable with a -1.2% profit margin. The path to breakeven will be the key catalyst.

What to Watch Next

Growth sustainability: can Phreesia Inc maintain 46%+ revenue growth, or will competition slow it down?

Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact Phreesia Inc.

Bottom Line

Phreesia Inc is a high-conviction growth story with revenue accelerating at 46% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin -1.2% margins and premium valuation suggest patience until the unit economics mature further.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions(30 last 3 months)

Total Buys
8
Total Sells
22
Mar 19, 2026(1 transaction)
PALE, FIRE CAPITAL SE
10% Owner
Buy
Shares
+780,009
Mar 17, 2026(1 transaction)
PALE, FIRE CAPITAL SE
10% Owner
Buy
Shares
+303,300
Jan 14, 2026(1 transaction)
HUI, YVONNE
Principal Accounting Officer
Sell
Shares
-365

Data sourced from SEC Form 4 filings

Last updated: 10:05:37 AM

About Phreesia Inc(PHR)

Exchange

NYSE

Sector

HEALTHCARE

Industry

HEALTH INFORMATION SERVICES

Country

USA

Phreesia, Inc. provides integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company is headquartered in Raleigh, North Carolina.